SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-07-29 16:39
Tx date 2020-06-18
$GSD
Devonian Health Group Inc.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
620,000
Filed 2018-12-04
Tx date 2018-11-30
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$27,000
+450,000 vol
$0.06 each
450,000
Filed 2018-11-05
Tx date 2018-01-22
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-32,250
-150,000 vol
$0.215 each
150,000
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Digital Coins or Tokens
36 - Conversion or exchange
$6,000
+1,500 vol
$4.00 each
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-32,250
-150,000 vol
$0.215 each
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Digital Coins or Tokens
36 - Conversion or exchange
$6,000
+1,500 vol
$4.00 each
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-31,500
-150,000 vol
$0.21 each
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Digital Coins or Tokens
36 - Conversion or exchange
$6,000
+1,500 vol
$4.00 each
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-31,500
-150,000 vol
$0.21 each
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Digital Coins or Tokens
36 - Conversion or exchange
$6,000
+1,500 vol
$4.00 each
3,000
Filed 2018-11-05
Tx date 2018-01-22
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
300,000
Filed 2018-11-05
Tx date 2018-01-22
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Digital Coins or Tokens
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-05
Tx date 2018-01-22
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Digital Coins or Tokens
36 - Conversion or exchange
$6,000
+1,500 vol
$4.00 each
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Digital Coins or Tokens
36 - Conversion or exchange
$6,000
+1,500 vol
$4.00 each
1,500
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-32,250
-150,000 vol
$0.215 each
Filed 2018-11-05
Tx date 2018-10-31
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-31,500
-150,000 vol
$0.21 each
0
Filed 2018-02-06
Tx date 2017-09-18
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.)
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,000
+100,000 vol
$0.25 each
100,000
Filed 2018-02-06
Tx date 2017-09-18
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.)
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-31
Tx date 2018-01-22
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-31
Tx date 2018-01-22
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-31
Tx date 2018-01-22
$CSQ
Canamex Gold Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-05-25
Tx date 2017-05-19
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-20,500
-100,000 vol
$0.205 each
169,191
Filed 2017-05-12
Tx date 2017-05-08
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,560
-72,000 vol
$0.23 each
337,191
Filed 2017-05-12
Tx date 2017-05-08
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-14,960
-68,000 vol
$0.22 each
269,191
Filed 2017-05-05
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-18,000
-300,000 vol
$0.06 each
150,000
Filed 2017-05-05
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$18,000
+300,000 vol
$0.06 each
409,191
Filed 2017-05-04
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,750
-50,000 vol
$0.255 each
309,191
Filed 2017-05-04
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,500
-50,000 vol
$0.25 each
359,191
Filed 2017-05-04
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-23,500
-100,000 vol
$0.235 each
109,191
Filed 2017-05-04
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-23,140
-100,000 vol
$0.2314 each
209,191
Filed 2017-04-26
Tx date 2017-04-04
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-10,370
-50,000 vol
$0.2074 each
809,191
Filed 2017-04-26
Tx date 2017-04-04
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-86.00
-430 vol
$0.20 each
859,191
Filed 2017-04-26
Tx date 2017-04-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,500
-50,000 vol
$0.17 each
859,621
Filed 2017-04-26
Tx date 2017-04-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,862.50
-73,500 vol
$0.175 each
909,621
Filed 2017-04-26
Tx date 2017-04-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,770
-26,500 vol
$0.18 each
1,033,121
Filed 2017-04-26
Tx date 2017-04-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,250
-50,000 vol
$0.185 each
983,121
Filed 2017-04-26
Tx date 2017-04-20
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-27,230
-100,000 vol
$0.2723 each
409,191
Filed 2017-04-26
Tx date 2017-04-06
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,125
-25,000 vol
$0.205 each
509,191
Filed 2017-04-26
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-30,750
-150,000 vol
$0.205 each
534,191
Filed 2017-04-26
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,375
-75,000 vol
$0.205 each
684,191
Filed 2017-04-26
Tx date 2017-04-04
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-10,250
-50,000 vol
$0.205 each
759,191
Filed 2017-04-03
Tx date 2017-03-24
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$90,000
+750,000 vol
$0.12 each
1,059,621
Filed 2016-12-16
Tx date 2016-12-12
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$5,813
+59,621 vol
$0.0975 each
309,621
Filed 2016-05-06
Tx date 2016-05-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,000
+200,000 vol
$0.05 each
250,000
Filed 2016-05-06
Tx date 2014-09-16
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2016-04-13
Tx date 2014-09-16
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-13
Tx date 2015-11-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$4,500
+50,000 vol
$0.09 each
450,000
Filed 2016-04-13
Tx date 2015-08-20
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$18,000
+300,000 vol
$0.06 each
400,000
Filed 2016-04-13
Tx date 2014-09-17
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$33,000
+100,000 vol
$0.33 each
100,000